Epitalon and related peptides are not registered as therapeutic substances, dietary supplements or cosmetic ingredients
In addition, due to such compensation, First Trust has an incentive to sell private investments issued by FTCM or offered through the First Trust Private Investment Platform, resulting in a material conflict of interest which should be considered when making a decision to invest in private funds offered by or through FTCM
Further, as the enanthate and cypionate esters have very similar time-release structures, total serum levels should be relatively the same with either compound, even if injected subcutaneously
At Formation, GHK-Cu is part of a supervised plan, never a guess
Clinical Evidence: Several studies support the potential benefits of BPC-157 in normalizing blood pressure: a) A study published in the Journal of Physiology and Pharmacology demonstrated that BPC-157 administration effectively reduced hypertension in rats, indicating its potential antihypertensive properties